이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Japan Lifeline 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Keisuke Suzuki

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	19yrs
CEO 소유권	14.9%
경영진 평균 재임 기간	6yrs
이사회 평균 재임 기간	7yrs

최근 관리 업데이트

Recent updates

Japan Lifeline Co., Ltd. Just Missed EPS By 6.2%: Here's What Analysts Think Will Happen Next

May 06

Japan Lifeline (TSE:7575) Is Increasing Its Dividend To ¥42.00

Mar 02

CEO

Keisuke Suzuki (71 yo)

19yrs

테뉴어

Mr. Keisuke Suzuki has been the President of Japan Lifeline Co., Ltd. since June 2005 and serves as its Chief Executive Officer since June 2005. Mr. Suzuki served as Vice President of Japan Lifeline Co., L...

리더십 팀

이름	위치	테뉴어	보상	소유권
Keisuke Suzuki	President	19yrs	데이터 없음	14.93% ¥ 12.7b
Atsuhiro Suzuki	Senior EVP	9yrs	데이터 없음	0.48% ¥ 405.6m
Kenji Yamada	Senior VP	less than a year	데이터 없음	0.036% ¥ 30.6m
Takayuki Kuronuma	Consultant	5yrs	데이터 없음	데이터 없음
Toru Takamiya	VP, Executive Manager of R&D and Manufacturing Headquarters & Director	7yrs	데이터 없음	0.0053% ¥ 4.5m
Tadashi Idei	VP, Executive Manager of Regulatory Affairs Headquarters & Director	7yrs	데이터 없음	0.0067% ¥ 5.7m
Yumiko Hoshiba	VP, Sr. Manager of Gr. Aff. Dep. of Corp. Admi. Headq.	6yrs	데이터 없음	0.023% ¥ 19.3m
Tatsuya Murase	SVP, Executive Manager of General Business Headquarters & Director	3.9yrs	데이터 없음	0.0067% ¥ 5.7m
Shigeki Kitayama	Operating Officer & Senior Manager of EP Department of Arrhythmia Business Unit	no data	데이터 없음	데이터 없음
Naohiro Nakada	Operating Officer	no data	데이터 없음	데이터 없음
Takahiko Suzuki	Operating Officer	no data	데이터 없음	데이터 없음
Takeyoshi Egawa	VP, Senior Manager of Business Administration Dept.	less than a year	데이터 없음	0.0027% ¥ 2.3m

6.0yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 관리: 7575 의 관리팀은 노련하고 경험 (평균 재직 기간 5.5 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Keisuke Suzuki	President	19yrs	데이터 없음	14.93% ¥ 12.7b
Atsuhiro Suzuki	Senior EVP	9yrs	데이터 없음	0.48% ¥ 405.6m
Kenji Yamada	Senior VP	no data	데이터 없음	0.036% ¥ 30.6m
Toru Takamiya	VP, Executive Manager of R&D and Manufacturing Headquarters & Director	7yrs	데이터 없음	0.0053% ¥ 4.5m
Tadashi Idei	VP, Executive Manager of Regulatory Affairs Headquarters & Director	7yrs	데이터 없음	0.0067% ¥ 5.7m
Yumiko Hoshiba	VP, Sr. Manager of Gr. Aff. Dep. of Corp. Admi. Headq.	6yrs	데이터 없음	0.023% ¥ 19.3m
Tatsuya Murase	SVP, Executive Manager of General Business Headquarters & Director	2yrs	데이터 없음	0.0067% ¥ 5.7m
Takeyoshi Egawa	VP, Senior Manager of Business Administration Dept.	less than a year	데이터 없음	0.0027% ¥ 2.3m
Fumihiro Sasaki	Independent Outside Director	12yrs	데이터 없음	0.0053% ¥ 4.5m
Yoshiaki Ikei	Independent Outside Director	7yrs	데이터 없음	0.0053% ¥ 4.5m
Yutaka Karigome	Independent Outside Director	3yrs	데이터 없음	데이터 없음
Shogo Takahashi	Director	no data	데이터 없음	0.029% ¥ 24.9m

7.0yrs

평균 재임 기간

60.5yo

평균 연령

경험이 풍부한 이사회: 7575 의 이사회는 경험(평균 재직 기간 6 년)으로 간주됩니다.

Japan Lifeline 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 26, 2024

Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit

Japan Lifeline Co., Ltd. Announces Management Changes

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 28, 2023

Japan Lifeline Announces Changes in Board of Directors, Effective June 28, 2023

Japan Lifeline Co., Ltd. Announces Executive Changes, Effective October 1, 2022 Respectively

Recent updates

Full year 2024 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd. to Report Q1, 2025 Results on Jul 31, 2024

Japan Lifeline Co., Ltd. Proposes Dividend for the Fiscal Year Ended March 31, 2024

Japan Lifeline Co., Ltd. Just Missed EPS By 6.2%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 26, 2024

Upcoming dividend of JP¥42.00 per share

Japan Lifeline (TSE:7575) Is Increasing Its Dividend To ¥42.00

Japan Lifeline Co., Ltd. to Report Q4, 2024 Results on May 01, 2024

Price target increased by 11% to JP¥1,400

Third quarter 2024 earnings released: EPS: JP¥28.32 (vs JP¥11.15 in 3Q 2023)

Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024

Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit

Price target increased by 11% to JP¥1,258

New major risk - Revenue and earnings growth

Japan Lifeline Co., Ltd. Announces Management Changes

Japan Lifeline Co., Ltd. to Report Q3, 2024 Results on Feb 02, 2024

Second quarter 2024 earnings released: EPS: JP¥22.31 (vs JP¥22.54 in 2Q 2023)

Price target increased by 13% to JP¥1,280

Now 23% undervalued

Now 21% undervalued

Japan Lifeline Co., Ltd. Announces That It Will Start Selling A New Lineup of Its Proprietary Open Stent Graft Product Frozenix Partial ET from August 2023

Now 23% undervalued

First quarter 2024 earnings released: EPS: JP¥30.02 (vs JP¥24.73 in 1Q 2023)

Japan Lifeline Co., Ltd. to Report Q2, 2024 Results on Nov 06, 2023

Full year 2023 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 28, 2023

Japan Lifeline Announces Changes in Board of Directors, Effective June 28, 2023

Upcoming dividend of JP¥38.00 per share at 4.1% yield

Japan Lifeline Co., Ltd. Revises Financial Forecast of Consolidated Financial Results for the Year Ending March 31, 2023

Third quarter 2023 earnings released: EPS: JP¥11.15 (vs JP¥24.01 in 3Q 2022)

Now 21% undervalued after recent price drop

Second quarter 2023 earnings released: EPS: JP¥23.64 (vs JP¥23.49 in 2Q 2022)

Second quarter 2023 earnings released: EPS: JP¥23.64 (vs JP¥23.49 in 2Q 2022)

Japan Lifeline Co., Ltd. Provides Year End Dividend Guidance for the Year Ending March 31, 2023

Consensus forecasts updated

Japan Lifeline Co., Ltd. Launches Series of In-House Products for Biliary-Pancreatic Endoscopy

Japan Lifeline Co., Ltd. Announces Executive Changes, Effective October 1, 2022 Respectively

Japan Lifeline Co., Ltd. to Report Q3, 2023 Results on Feb 01, 2023

First quarter 2023 earnings released: EPS: JP¥24.73 (vs JP¥21.17 in 1Q 2022)

Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for Six Months Ending September 30, 2022 and Year Ending March 31, 2023

Japan Lifeline Co., Ltd. to Report Q2, 2023 Results on Nov 02, 2022

Price target decreased to JP¥1,120

Japan Lifeline Co., Ltd. Announces Dividend for Year Ended March 31, 2022, Effective Date Is June 29, 2022

Full year 2022 earnings: EPS in line with expectations, revenues disappoint

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 28, 2022

Consensus EPS estimates fall by 12%

Japan Lifeline Co., Ltd. Appoints Shigeki Kitayama as Operating Officer

Upcoming dividend of JP¥38.00 per share

Third quarter 2022 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022

Price target decreased to JP¥1,500

Japan Lifeline Co., Ltd. Provides Earnings Guidance for the Six Months Ending September 30, 2021 and Full Year of Ending March 31, 2022

First quarter 2022 earnings released: EPS JP¥21.17 (vs JP¥10.53 in 1Q 2021)

Metcela Inc. and Japan Lifeline Co., Ltd. Announces Initiation of Phase I Clinical Trial of MTC001 in Patients with Chronic Ischemic Heart Failure

VP, GM of CRM Business Division & Director Osamu Watanabe has left the company

Japan Lifeline Receives Regulatory Approval for HeartLight X3

Japan Lifeline Co., Ltd. Receives Regulatory Approval for Abdominal Stent Graft Alto

Full year 2021 earnings released: EPS JP¥24.90 (vs JP¥96.55 in FY 2020)

Japan Lifeline Co., Ltd. Provides Year End Cash Dividend Guidance for the Year Ending March 31, 2022

Consensus forecasts updated

Upcoming dividend of JP¥49.00 per share

New 90-day low: JP¥1,365

Cardiofocus, Inc. Announces Expanded Partnership with Japan Lifeline Co., Ltd

Third quarter 2021 earnings released: JP¥31.57 loss per share (vs JP¥27.44 profit in 3Q 2020)

Revenue and earnings miss expectations

Analysts update estimates

New 90-day high: JP¥1,633

Japan Lifeline Co., Ltd. Announces Changes in Personnel